(Q36138225)

English

Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study (English)

1 reference

Europe PubMed Central

12 August 2017

type-1 diabetes

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

object named as

A Jorsal

4

0 references

Isabel Ferreira

object named as

I Ferreira

2

0 references

object named as

L Tarnow

7

0 references

Coenraad Dirk Adriaan Stehouwer

9

object named as

C D A Stehouwer

1 reference

Europe PubMed Central

12 August 2017

Casper G. Schalkwijk

3

object named as

C G Schalkwijk

1 reference

Europe PubMed Central

12 August 2017

author name string

J W M Nin

1

1 reference

Europe PubMed Central

12 August 2017

M H Prins

5

1 reference

Europe PubMed Central

12 August 2017

H-H Parving

6

1 reference

Europe PubMed Central

12 August 2017

P Rossing

8

1 reference

Europe PubMed Central

12 August 2017

publication date

1 July 2012

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

55

1 reference

Europe PubMed Central

12 August 2017

9

1 reference

Europe PubMed Central

12 August 2017

2489-2493

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1007/s00125-012-2622-1

0 references

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411294

2 October 2017

HMGB1 and RAGE in inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411294

2 October 2017

Role of HMGB1 in cardiovascular diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411294

2 October 2017

Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411294

2 October 2017

High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3411294

23 September 2018

Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2622-1

21 January 2018

HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum HMGB1 is related to the severity of coronary artery stenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22752054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-012-2622-1

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36138225&oldid=1964658352"